Condition: Degenerative Disc Disease · Spine Fusion · Back Pain · Sponsor: Kuros Biosurgery AG
This is a phase IV post-marketing study for MagnetOs Easypack Putty. MagnetOs Easypack Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease or spinal trauma undergoing spinal fusion surgery. In this study, MagnetOs Easypack Putty will be used according to the latest U.S. Instructions For Use, standalone in the posterolateral spine.
This description comes directly from the study's public registry record.
Cesar Silva, MD · 9702156793 · cesar.silva@kurosbio.com
Always discuss trial participation with your own doctor first.
| The Regents of the University of California- Irvine Campus | Irvine, California, United States | Recruiting |
| Corewell Health | Grand Rapids, Michigan, United States | Recruiting |
| The Washington University | St Louis, Missouri, United States | Recruiting |
| Rothman Orthopaedic Institute | Philadelphia, Pennsylvania, United States | Recruiting |
| Tennessee Orthopaedic Alliance | Nashville, Tennessee, United States | Recruiting |
| University of Washington | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04679844